Q: How does Orladeyo work?

Mechanism of Action Orladeyo belongs to a class of medications known as plasma kallikrein inhibitors. It is designed to prevent attacks of hereditary angioedema (HAE) by targeting the underlying cause of swelling in the body. In people with HAE, an enzyme called plasma kallikrein becomes overactive. This overactivity leads to the excessive release of a substance called bradykinin. Bradykinin is a natural peptide that causes blood vessels to widen and leak fluid into nearby tissues, which results in localized swelling, pain, and inflammation. Orladeyo works by: Binding to the plasma kallikrein enzyme. Reducing the enzyme's ability to produce bradykinin. Lowering the overall levels of bradykinin in the body. By keeping bradykinin levels under control, the medication helps prevent the blood vessels from leaking, thereby reducing the frequency of HAE attacks. It is important to note that Orladeyo is a preventive treatment and is not intended to treat an acute HAE attack once it has already started.

Q: What are the active ingredients in Orladeyo?

The active ingredient in Orladeyo is berotralstat .

Q: What are the side effects of Orladeyo?

Common side effects of Orladeyo may include: Abdominal pain Diarrhea Nausea Always consult with a healthcare professional about potential side effects.

Q: What drug class is Orladeyo?

Orladeyo belongs to the plasma kallikrein inhibitor drug class.

Q: What is the dosage of Orladeyo and how do I take it?

How to Take This Medication Orladeyo is typically taken once a day. It should be swallowed whole with food. Do not crush, chew, or open the capsules. It is helpful to take the medication at the same time each day to maintain a consistent level in your body. Missed Dose If you miss a dose of Orladeyo, skip the missed dose and take your next dose at the regular scheduled time. Do not take two doses at once or take more than one dose in a single day to make up for a missed one. Storage and Handling Store the capsules at room temperature in a dry place. Keep the medication in its original container and out of reach of children.

Q: Is Orladeyo safe during pregnancy and breastfeeding?

Pregnancy Data regarding the use of Orladeyo in pregnant individuals are insufficient to determine if there is a drug-associated risk for major birth defects, miscarriage, or other adverse outcomes. In animal reproduction studies, no evidence of harm to the fetus was observed when berotralstat was administered at doses significantly higher than the recommended human dose. If you are pregnant or planning to become pregnant, talk to your doctor about the potential benefits and risks of using this medication during pregnancy. Breastfeeding It is not known whether Orladeyo passes into human breast milk, how it affects a nursing infant, or if it impacts milk production. Research in animals has shown that berotralstat is present in the milk of lactating rats. Because many drugs are excreted in human milk, caution is advised. Consult your healthcare provider to discuss the best way to feed your baby while taking Orladeyo and to weigh the benefits of breastfeeding against the potential risks to the infant.

Q: What is the FDA approval status of Orladeyo?

FDA Approval Status Orladeyo (berotralstat) received approval from the U.S. Food and Drug Administration (FDA) in December 2020. It is classified as a plasma kallikrein inhibitor and was the first oral, non-steroidal treatment option approved for preventing hereditary angioedema (HAE) attacks. Approved Indications The FDA has approved Orladeyo for the following use: Routine prophylaxis to prevent attacks of hereditary angioedema in adults and pediatric patients 12 years of age and older. Limitations of Use The safety and effectiveness of Orladeyo for the treatment of acute HAE attacks have not been established. This medication should not be used for the immediate treatment of an ongoing attack; patients should follow their prescribed rescue medication plan for acute symptoms. Regulatory Requirements There are no Boxed Warnings associated with Orladeyo. Additionally, the FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for this medication. It is available only by prescription.

Question 1

What is Orladeyo?

Accepted Answer

Orladeyo is a plasma kallikrein inhibitor that works by decreasing the activity of an enzyme responsible for fluid leakage and inflammation in the body. By regulating this pathway, the medication helps control the biological processes that lead to sudden and severe swelling.

This therapy is designed to provide ongoing management of the proteins that trigger inflammatory responses. It functions by limiting the production of certain substances in the blood that cause blood vessels to dilate and leak fluid into surrounding tissues.

Question 2

What is Orladeyo used for?

Accepted Answer

Orladeyo is used to treat routine prevention of hereditary angioedema attacks.

Question 3

How does Orladeyo work?

Accepted Answer

Mechanism of Action

Orladeyo belongs to a class of medications known as plasma kallikrein inhibitors. It is designed to prevent attacks of hereditary angioedema (HAE) by targeting the underlying cause of swelling in the body.

In people with HAE, an enzyme called plasma kallikrein becomes overactive. This overactivity leads to the excessive release of a substance called bradykinin. Bradykinin is a natural peptide that causes blood vessels to widen and leak fluid into nearby tissues, which results in localized swelling, pain, and inflammation.

Orladeyo works by:

Binding to the plasma kallikrein enzyme.
Reducing the enzyme's ability to produce bradykinin.
Lowering the overall levels of bradykinin in the body.

By keeping bradykinin levels under control, the medication helps prevent the blood vessels from leaking, thereby reducing the frequency of HAE attacks. It is important to note that Orladeyo is a preventive treatment and is not intended to treat an acute HAE attack once it has already started.

Question 4

What are the active ingredients in Orladeyo?

Accepted Answer

The active ingredient in Orladeyo is berotralstat.

Question 5

What are the side effects of Orladeyo?

Accepted Answer

Common side effects of Orladeyo may include:

Abdominal pain
Diarrhea
Nausea

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Orladeyo?

Accepted Answer

Orladeyo belongs to the plasma kallikrein inhibitor drug class.

Question 7

What is the dosage of Orladeyo and how do I take it?

Accepted Answer

How to Take This Medication

Orladeyo is typically taken once a day. It should be swallowed whole with food. Do not crush, chew, or open the capsules. It is helpful to take the medication at the same time each day to maintain a consistent level in your body.

Missed Dose

If you miss a dose of Orladeyo, skip the missed dose and take your next dose at the regular scheduled time. Do not take two doses at once or take more than one dose in a single day to make up for a missed one.

Storage and Handling

Store the capsules at room temperature in a dry place. Keep the medication in its original container and out of reach of children.

Question 8

Is Orladeyo safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Data regarding the use of Orladeyo in pregnant individuals are insufficient to determine if there is a drug-associated risk for major birth defects, miscarriage, or other adverse outcomes. In animal reproduction studies, no evidence of harm to the fetus was observed when berotralstat was administered at doses significantly higher than the recommended human dose.

If you are pregnant or planning to become pregnant, talk to your doctor about the potential benefits and risks of using this medication during pregnancy.

Breastfeeding

It is not known whether Orladeyo passes into human breast milk, how it affects a nursing infant, or if it impacts milk production. Research in animals has shown that berotralstat is present in the milk of lactating rats. Because many drugs are excreted in human milk, caution is advised.

Consult your healthcare provider to discuss the best way to feed your baby while taking Orladeyo and to weigh the benefits of breastfeeding against the potential risks to the infant.

Question 9

What forms and strengths does Orladeyo come in?

Accepted Answer

Orladeyo is supplied as a capsule for oral administration. It is intended to be taken by mouth, typically once daily with food.

Question 10

What is the FDA approval status of Orladeyo?

Accepted Answer

FDA Approval Status

Orladeyo (berotralstat) received approval from the U.S. Food and Drug Administration (FDA) in December 2020. It is classified as a plasma kallikrein inhibitor and was the first oral, non-steroidal treatment option approved for preventing hereditary angioedema (HAE) attacks.

Approved Indications

The FDA has approved Orladeyo for the following use:

Routine prophylaxis to prevent attacks of hereditary angioedema in adults and pediatric patients 12 years of age and older.

Limitations of Use

The safety and effectiveness of Orladeyo for the treatment of acute HAE attacks have not been established. This medication should not be used for the immediate treatment of an ongoing attack; patients should follow their prescribed rescue medication plan for acute symptoms.

Regulatory Requirements

There are no Boxed Warnings associated with Orladeyo. Additionally, the FDA does not require a Risk Evaluation and Mitigation Strategy (REMS) for this medication. It is available only by prescription.

Question 11

What should I know about Orladeyo and cost?

Accepted Answer

Insurance and Pharmacy Factors

The out-of-pocket cost for Orladeyo varies significantly based on your health insurance plan, including your specific deductible, co-pay, or co-insurance requirements. Because Orladeyo is a specialty medication, it is typically dispensed through a specialty pharmacy rather than a standard retail pharmacy, which may affect how the drug is billed and delivered.

Financial Assistance Programs

The manufacturer of Orladeyo offers patient support services that may help reduce costs for eligible individuals. These programs often include:

Co-pay assistance: Financial support for patients with commercial insurance to help cover out-of-pocket expenses.
Patient assistance: Programs that may provide the medication at no cost for patients who are uninsured or meet specific financial criteria.

Generic Availability

There is currently no generic version of Orladeyo available. As a brand-name medication, it may have a higher cost than older treatments or generic drugs used for other conditions. To determine your specific costs, it is recommended to contact your insurance provider or the specialty pharmacy designated by your healthcare provider.

Orladeyo

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

Found an Error?

Find Discounts for Orladeyo

Hospitals.net Disclosure